Autolus Therapeutics Ltd (AUTL) Live Share Price, Invest From India

Autolus Therapeutics Ltd Stock Performance

as on April 18, 2026 at 6:59 am IST

Day's High
$1.60
Day's Price Range
$1.69
$1.60
5.62%
Upside
52 Week's Low
52 Week's High
$1.15
52-Week Price Range
$2.70
$1.60
28.13%
Downside
68.75%
Upside

Autolus Therapeutics Ltd share price movements today

Previous Close: $1.61
Open: $1.63
Volume: 2.9M
Day's Low - High: $1.60 - $1.69
52 Week Low - High: $1.15 - $2.70

Autolus Therapeutics Ltd Historical Returns

1 Month Return: + 6.62 %
3 Month Return: + 16.67 %
1 Year Return: + 12.59 %
3 Year Return: -12.5 %
5 Year Return: -69.57 %

Autolus Therapeutics Ltd Stock Fundamentals & Key Indicators

Check Autolus Therapeutics Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$428.5M

EPS (TTM)

-0.9338

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-68.9M

Revenue (TTM)

1.1M

Profit Margin

0.00%

Return On Equity TTM

-29.62%

Autolus Therapeutics Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Autolus Therapeutics Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Autolus Therapeutics Ltd	BUY	$428.5M	-69.57%	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$42.7B	130.51%	136.81	8.45%
Vertex Pharmaceuticals Inc	BUY	$110.8B	98.57%	28.42	32.94%
BeiGene, Ltd.	NA	$36.8B	NA	129.84	5.37%
Regeneron Pharmaceuticals Inc	BUY	$78.9B	48.43%	17.98	31.41%

Stock Returns calculator for Autolus Therapeutics Ltd Stock including INR - Dollar returns

The Autolus Therapeutics Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Autolus Therapeutics Ltd investment value today

Current value as on today

₹1,21,556

Returns

₹21,556

(+21.56%)

Returns from Autolus Therapeutics Ltd Stock

₹11,888 (+11.89%)

Dollar Impact

₹9,668 (+9.67%)

Analyst Recommendation on Autolus Therapeutics Ltd Stock

Based on 17 analysts

BUY

82.35%

Buy

17.65%

Hold

0.00%

Sell

Based on 17 analysts, 82.35% of analysts recommend a 'BUY' rating for Autolus Therapeutics Ltd. Average target price of $8.81

Autolus Therapeutics Ltd Share Price Target

Get share price movements and forecasts by analysts on Autolus Therapeutics Ltd.

What analysts predicted

81.84%UPSIDE

Target Price

$8.81

Current Price

$1.6

Analyzed by

17 Analysts

Target

$8.81

Autolus Therapeutics Ltd target price $8.81, a slight upside of 81.84% compared to current price of $1.6. According to 17 analysts rating.

Autolus Therapeutics Ltd Stock’s Investor Sentiment and Interest

Search interest for Autolus Therapeutics Ltd Stock has increased by 11% in the last 30 days, reflecting an upward trend in search activity.

Time period: March 19, 2026 to April 18, 2026

Change:11% versus previous 30 day period

Autolus Therapeutics Ltd Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	0	1	10	-	-	0	8	20	21	24
Gross Profit	-1	-1	8	-1	-1	-138	-8	-3	-7	-1
Operating Income	-44	-40	-38	-58	-68	-241	-65	-61	-71	-72
EBITDA	-41	-32	-31	-43	-65	-73	-55	-56	-64	-72
Interest Expense	5	30	19	10	10	30	10	-	10	22
Depreciation	1	1	1	1	1	2	2	4	3	0
Income Before Tax	-45	-64	-52	-58	-82	-26	-67	-47	-78	-91
Income Tax Expense	0	12	0	0	0	1	2	0	0	-1
Net Income	-45	-77	-52	-58	-82	-27	-70	-47	-79	-90
Net Profit Margin	-11292.86%	-4347.66%	-522.15%	0.00%	0.00%	-95193.10%	-781.13%	-229.02%	-373.30%	-371.90%

Autolus Therapeutics Ltd Annual Profit & Loss

All numbers in Millions USD

	Sep 2020	Dec 2020	Sep 2021	Dec 2021	Sep 2022	Dec 2022	Sep 2023	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	1	2	1	6	6	1	1	10	75
Gross Profit	-	-133	-	1	-	6	-	1	-130	-21
Operating Income	-	-303	-	-140	-	-142	-	-179	-241	-281
EBITDA	-	-162	-	-132	-	-132	-	-156	-233	-271
Interest Expense	-	1	-	1	-	8	-	45	9	36
Depreciation	-	5	-	8	-	7	-	6	7	9
Income Before Tax	-	-166	-	-142	-	-148	-	-208	-219	-296
Income Tax Expense	-	-24	-	0	-	0	-	0	1	1
Net Income	-142	-142	-142	-142	-148	-148	-208	-208	-220	-287
Net Profit Margin	-58716.53%	-8285.36%	-6098.54%	-9429.06%	-2402.95%	-2402.95%	-12272.26%	-12272.26%	-2180.45%	-380.51%

Autolus Therapeutics Ltd Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-77	-52	-58	-82	-27	-70	-47	-79	-90
Operating Cash Flow	-24	-40	-51	-76	-37	-75	-72	-67	-67
Investing Cash Flow	-1	0	0	-9	-383	-59	95	35	86
Financing Cash Flow	0	561	-2	0	30	-	0	-1	-1
Change in Cash	-16	519	-52	-48	-429	-131	28	-37	18

Autolus Therapeutics Ltd Annual Cash Flow

All numbers in Millions USD

	Sep 2018	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-31	-31	-123	-142	-142	-148	-208	-220	-287
Operating Cash Flow	-25	-25	-101	-117	-117	-112	-145	-206	-283
Investing Cash Flow	-9	-7	-18	-14	-8	-10	-10	-394	158
Financing Cash Flow	117	117	108	74	284	223	0	589	-4
Change in Cash	86	86	-6	-57	156	72	-142	-11	-123

Global Institutional Holdings in Autolus Therapeutics Ltd

Funds	Holdings
LAURION CAPITAL MANAGEMENT LP	1.25%
Susquehanna International Group, LLP	0.23%
Polygon Management Ltd	3.57%
Acadian Asset Management LLC	0.7%
LAURION CAPITAL MANAGEMENT LP	1.25%

See all

Insights on Autolus Therapeutics Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, AUTL stock has moved up by 16.7%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 5 quarters, 29.0K → 24.25M (in $), with an average increase of 42.7% per quarter
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 38.8% return, outperforming this stock by 26.2%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 20.2% return, outperforming this stock by 33.6%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -47.91M → -90.20M (in $), with an average decrease of 39.6% per quarter

About Autolus Therapeutics Ltd

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in the United Kingdom and internationally. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a programmed T cell investigational therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1 and TRBC2; AUTO6NG, a programmed T cell investigational therapy targeting GD2 in development for the treatment of neuroblastoma; and AUTO8, a product candidate to treat multiple myeloma. It focuses on developing AUTO5, a preclinical TRBC2 programmed T cell product candidate for the treatment of peripheral T-cell lymphoma. The company was incorporated in 2014 and is headquartered in London, the United Kingdom.

Organisation	Autolus Therapeutics Ltd
Headquarters	The Mediaworks, London, United Kingdom, W12 7FP
Industry	Biotechnology
CEO	Dr. Christian Martin Itin Ph.D.
E-voting on shares	Click here to vote

Key Management of Autolus Therapeutics Ltd

Name	Title
Mr. Robert F. Dolski	Senior VP & CFO
Mr. Christopher Vann	Senior VP & COO
Ms. Miranda Neville	Senior VP & Chief Technology Officer
Dr. Matthias Will M.D.	Senior VP & Chief Development Officer
Dr. Christian Martin Itin Ph.D.	CEO & Director
Dr. Martin Pule M.D., MBBS	Founder, Senior VP & Chief Scientific Officer
Mr. Patrick McIlvenny	Senior VP of Finance, Chief Accounting Officer & Principal Accounting Officer
Mr. Alex Driggs	Senior VP of Legal Affairs & General Counsel and Secretary
Mr. Alexander Swan	Senior VP & Chief Human Resources Officer
Dr. Christopher Williams Ph.D.	Senior VP & Chief Business Development Officer

FAQs

What is Autolus Therapeutics Ltd share price today?

Autolus Therapeutics Ltd share price today is $1.6 as on April 18, 2026 at 1:29 am IST at the close of the market. Autolus Therapeutics Ltd share today touched a day high of $1.69 and a low of $1.6.

What is the 52 week high and 52 week low for Autolus Therapeutics Ltd share?

Autolus Therapeutics Ltd share touched a 52 week high of $2.7 on July 24, 2025 and a 52 week low of $1.15 on May 7, 2025. Autolus Therapeutics Ltd stock price today i.e. April 18, 2026 at 1:29 am IST is closed at $1.6,which is 40.74% down from its 52 week high and 39.13% up from its 52 week low.

What is Autolus Therapeutics Ltd's market capitalisation today?

Autolus Therapeutics Ltd market capitalisation is $0.00T as on April 18, 2026 at 1:29 am IST.

How to invest in Autolus Therapeutics Ltd Stock (AUTL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Autolus Therapeutics Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Autolus Therapeutics Ltd Shares that will get you 0.9375 shares as per Autolus Therapeutics Ltd share price of $1.6 per share as on April 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Autolus Therapeutics Ltd Stock (AUTL) from India?

Indian investors can start investing in Autolus Therapeutics Ltd (AUTL) shares with as little as ₹92.768 or $1 (as of April 18, 2026 at 9:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in Autolus Therapeutics Ltd stock (as per the Rupee-Dollar exchange rate as on April 18, 2026 at 9:37 am IST). Based on Autolus Therapeutics Ltd share’s latest price of $1.6 as on April 18, 2026 at 1:29 am IST, you will get 6.2500 shares of Autolus Therapeutics Ltd. Learn more about fractional shares .

What are the returns that Autolus Therapeutics Ltd has given to Indian investors in the last 5 years?

Autolus Therapeutics Ltd stock has given -69.57% share price returns and 24.45% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?